Theophylline as a therapy for chronic lymphocytic leukemia: a case report and review of literature

Theophylline as a therapy for chronic lymphocytic leukemia: a case report and review of literature Haematologia , Vol. 30, No. 3, pp. 225 – 227 (2000) Ó VSP 2000. Case report Theophylline as a therapy for chronic lymphocytic leukemia: a case report and review of literature SUJIT BASU 1 , ∗ and RITA MITRA (BASU) 2 1 Department of Medical Oncology, Chittaranjan National Cancer Institute, Calcutta, India 2 Department of Pathology, Institute of Post-Graduate Medical Education and Research, Calcutta, India Abstract —We herein, report that theophylline which can induce apoptosis in chronic lymphocytic leukemia (CLL) cells both in vitro and in vivo , also appears to be effective when used clinically to treat an advanced CLL patient. Key words : CLL; theophylline. INTRODUCTION Theophylline, a methylxanthine which has been extensively used for the treat- ment of bronchial asthma acts by inhibiting phosphodiesterase, the enzyme re- sponsible for degradation of cyclic adenosine monophosphate (cAMP) to adeno- sine monophosphate (AMP) thereby accumulating cAMP [1, 2]. This second mes- senger in turn has been found to be involved in the regulation of many genes [3]. Interestingly,there are also reports which suggest that theophylline can induce apop- tosis in lymphocytes from chronic lymphocytic leukemia (CLL) patients indirectly through accumulation of cAMP both in vitro [4, 5] and http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Haematologia Brill

Theophylline as a therapy for chronic lymphocytic leukemia: a case report and review of literature

Haematologia, Volume 30 (3): 225 – Jan 1, 2000

Loading next page...
 
/lp/brill/theophylline-as-a-therapy-for-chronic-lymphocytic-leukemia-a-case-QnMF4qLKwF
Publisher
Brill
Copyright
© 2000 Koninklijke Brill NV, Leiden, The Netherlands
ISSN
0017-6559
eISSN
1568-5594
D.O.I.
10.1163/156855900300109242
Publisher site
See Article on Publisher Site

Abstract

Haematologia , Vol. 30, No. 3, pp. 225 – 227 (2000) Ó VSP 2000. Case report Theophylline as a therapy for chronic lymphocytic leukemia: a case report and review of literature SUJIT BASU 1 , ∗ and RITA MITRA (BASU) 2 1 Department of Medical Oncology, Chittaranjan National Cancer Institute, Calcutta, India 2 Department of Pathology, Institute of Post-Graduate Medical Education and Research, Calcutta, India Abstract —We herein, report that theophylline which can induce apoptosis in chronic lymphocytic leukemia (CLL) cells both in vitro and in vivo , also appears to be effective when used clinically to treat an advanced CLL patient. Key words : CLL; theophylline. INTRODUCTION Theophylline, a methylxanthine which has been extensively used for the treat- ment of bronchial asthma acts by inhibiting phosphodiesterase, the enzyme re- sponsible for degradation of cyclic adenosine monophosphate (cAMP) to adeno- sine monophosphate (AMP) thereby accumulating cAMP [1, 2]. This second mes- senger in turn has been found to be involved in the regulation of many genes [3]. Interestingly,there are also reports which suggest that theophylline can induce apop- tosis in lymphocytes from chronic lymphocytic leukemia (CLL) patients indirectly through accumulation of cAMP both in vitro [4, 5] and

Journal

HaematologiaBrill

Published: Jan 1, 2000

Keywords: theophylline; CLL

There are no references for this article.

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off